EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut microbiota-derived butyrate improved acute leptospirosis in hamster via promoting macrophage ROS mediated by HDAC3 inhibition

Xi Chen, Xufeng Xie, Ni Sun, Xin Liu, Jiuxi Liu, Wenlong Zhang iD, Yongguo Cao iD

mBio · 16.10.2024 · 15 (10)

DOI: 10.1128/mbio.01906-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 16.10.2024. Verfasst von Xi Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Leptospirosis, Gastrointestinal Microbiome, Butyrates, Histone Deacetylases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), China Postdoctoral Science Foundation (China Postdoctoral Foundation Project), Guangdong Basic Research Program and applied basic research project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptospirosis is a re-emerging worldwide zoonotic disease. Infected patients and animals often exhibit intestinal symptoms. Mounting evidence suggests that host immune responses to bacterial infection are closely associated with intestinal homeostasis. Our previous research has shown that the gut microbiota can protect the host from acute leptospirosis, while the specific bacterial metabolic mediators participating in the pathogenesis remain to be identified. Short-chain fatty acids (SCFAs) are metabolites produced mainly by the gut microbiota that play a role in immune regulation. However, whether SCFAs are the key to protecting the host against leptospirosis and the underlying regulatory mechanisms are unknown. In this study, our results showed that the SCFA butyrate is involved in ameliorating leptospirosis. The depletion of SCFAs by antibiotic cocktail treatment reduced survival time after Leptospira infection while supplementation with butyrate but not acetate or propionate significantly amelioration of leptospirosis. In vitro experiments showed that butyrate treatment enhanced the intracellular bactericidal activity mediated by reactive oxygen species (ROS) production. Mechanistically, butyrate functions as a histone deacetylase 3 inhibitor (HDAC3i) to promote ROS production via monocarboxylate transporter (MCT). The protection of butyrate against acute leptospirosis mediated by ROS was also proven in vivo . Collectively, our data provide evidence that the butyrate-MCT-HDAC3i-ROS signaling axis is a potential therapeutic target for acute leptospirosis. Our work not only interprets the microbial metabolite signaling involved in transkingdom interactions between the host and gut microbiota but also provides a possible target for developing a prevention strategy for acute leptospirosis. IMPORTANCE Leptospirosis is a worldwide zoonotic disease caused by Leptospira . An estimated 1 million people are infected with leptospirosis each year. Studies have shown that healthy gut microbiota can protect the host against leptospirosis but the mechanism is not clear. This work elucidated the mechanism of gut microbiota protecting the host against acute leptospirosis. Here, we find that butyrate, a metabolite of gut microbiota, can improve the survival rate of hamsters with leptospirosis by promoting the bactericidal activity of macrophages. Mechanistically, butyrate upregulates reactive oxygen species (ROS) levels after macrophage infection with Leptospira by inhibiting HDAC3. This work confirms the therapeutic potential of butyrate in preventing acute leptospirosis and provides evidence for the benefits of the macrophage-HDAC3i-ROS axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeptospirosisGastrointestinal MicrobiomeButyratesHistone DeacetylasesReactive Oxygen SpeciesMacrophagesAnimalsCricetinaeHistone Deacetylase InhibitorsFatty Acids, VolatileLeptospiraDisease Models, AnimalMaleHistone Deacetylase 3

Stichwörter der Autor:innen

HDAC3ROSbutyrateleptospirosismacrophage

Substanzen

ButyratesHistone DeacetylasesReactive Oxygen SpeciesHistone Deacetylase InhibitorsFatty Acids, VolatileHistone Deacetylase 3

Autor:innen und Institutionen

  • Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China.
  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…

ORCID-Profile: Wenlong Zhang, Yongguo Cao

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • China Postdoctoral Science Foundation (China Postdoctoral Foundation Project)
  • Guangdong Basic Research Program and applied basic research project
  • GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province ()

Zitieren

APA

Chen, X., Xie, X., Sun, N., Liu, X., Liu, J., Zhang, W., & Cao, Y. (2024). Gut microbiota-derived butyrate improved acute leptospirosis in hamster via promoting macrophage ROS mediated by HDAC3 inhibition. mBio, 15(10). https://doi.org/10.1128/mbio.01906-24

Vancouver

Chen X, Xie X, Sun N, Liu X, Liu J, Zhang W, et al. Gut microbiota-derived butyrate improved acute leptospirosis in hamster via promoting macrophage ROS mediated by HDAC3 inhibition. mBio. 2024;15(10). doi:10.1128/mbio.01906-24

BibTeX
@article{Chen2024,
  author = {Chen, Xi and Xie, Xufeng and Sun, Ni and Liu, Xin and Liu, Jiuxi and Zhang, Wenlong and Cao, Yongguo},
  title = {Gut microbiota-derived butyrate improved acute leptospirosis in hamster via promoting macrophage ROS mediated by HDAC3 inhibition},
  journal = {mBio},
  year = {2024},
  volume = {15},
  number = {10},
  doi = {10.1128/mbio.01906-24}
}
Kostenlos starten →